Site staff may begin recruitment upon completion of all action items required for endorsement, when
adequate staff is available and fully trained in their study roles, and after.
O A. The research site investigator sends a letter to the sponsor advising of their site-appointed start date.
O B. The research site has been inspected and received approval from an FDA Inspector.
OC. The Lead Investigator and sponsor have provided their approval.
OD. None of the above.